Concord Wealth Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.4K Buy
+267
New +$14.5K ﹤0.01% 554
2026
Q1
Sell
-3,907
Closed -$373K 272
2025
Q4
$373K Buy
3,907
+272
+7% +$26.7K 0.05% 155
2025
Q3
$355K Buy
3,635
+3,368
+1,261% +$349K 0.05% 161
2025
Q2
$28.7K Hold
267
﹤0.01% 414
2025
Q1
$26.9K Sell
267
-297
-53% -$29.9K ﹤0.01% 399
2024
Q4
$50.4K Hold
564
0.01% 327
2024
Q3
$47.3K Hold
564
0.01% 345
2024
Q2
$43.4K Sell
564
-57
-9% -$4.17K 0.01% 329
2024
Q1
$42.5K Hold
621
0.01% 378
2023
Q4
$35.9K Sell
621
-280
-31% -$14.9K 0.01% 401
2023
Q3
$47.6K Buy
901
+61
+7% +$3.2K 0.01% 386
2023
Q2
$45.4K Hold
840
0.01% 380
2023
Q1
$42K Buy
840
+314
+60% +$14.8K 0.01% 371
2022
Q4
$24.3K Buy
+526
New +$22.8K 0.01% 495
2022
Q3
Sell
-574
Closed -$21K 285
2022
Q2
$21K Sell
574
-1,563
-73% -$63.6K 0.01% 532
2022
Q1
$95K Sell
2,137
-74
-3% -$3.21K 0.02% 308
2021
Q4
$94K Buy
2,211
+1,578
+249% +$66.3K 0.02% 318
2021
Q3
$27K Sell
633
-1,023
-62% -$45.3K 0.01% 324
2021
Q2
$71K Buy
1,656
+259
+19% +$10.9K 0.02% 291
2021
Q1
$54K Buy
1,397
+1,368
+4,717% +$51.8K 0.02% 324
2020
Q4
$1K Buy
+29
New +$1.04K ﹤0.01% 601

Other funds holding BSX

Concord Wealth Partners's BSX Position: Q2 2026 in Review

Concord Wealth Partners opened a new position in Boston Scientific (BSX) in Q2 2026: 267 shares worth $11.4K. The stake represents ﹤0.01% of the portfolio and ranks #554 among its holdings. This is a return to the name: Concord Wealth Partners previously reported a position in BSX as recently as Q4 2025.

Concord Wealth Partners first reported a position in BSX in Q4 2020 and has held it in 21 quarters since. The position peaked at $373K in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Concord Wealth Partners held 267 shares of Boston Scientific worth $11.4K as of Q2 2026.
  • Boston Scientific was a new Concord Wealth Partners position in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Concord Wealth Partners's portfolio in Q2 2026, its #554 holding.
  • Concord Wealth Partners first reported a position in Boston Scientific in Q4 2020 and has held it in 21 quarters since.
  • Concord Wealth Partners's Boston Scientific position peaked at $373K in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.